# Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder

> **NCT00183430** · NA · TERMINATED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 20 (actual)

## Conditions studied

- Post-Traumatic Stress Disorder
- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** Prazosin
- **DRUG:** Placebo
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT00183430
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2009-05
- **Final completion:** 2010-12
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Insufficient Enrollment
- **Last updated:** 2018-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183430, "Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00183430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*